Talk Track 1 - Regulatory Science (RS) track
Advancing Global Collaboration and Operational Excellence
Wed, Nov 18, 2026 · 4:00–5:30 PM IST Main Auditorium, CIDCO Auditorium & Convention Centre
About this session
Session Overview: This session can include topics on international collaborative assessments, environmental risk assessment, and data governance/master data harmonization. The emphasis would be on improving efficiency, quality, and patient access through collaboration and robust operational practices Programme: RS.S3.T1: Seeing Risk Before It Becomes Failure: Leveraging Early Risk Intelligence in GMP Systems; RS.S3.T2: Advancing International Collaborative Regulatory Assessments to Accelerate Patient Access; RS.S3.T3: Driving Operational Excellence: Enhancing Data Quality and governance through Master-Reference Data Harmonization; RS.S3.T4: Panel Discussion: From Regulatory Silos to Global Collaboration: Can Convergence Accelerate Patient Access.
Speakers
-
Senior Director Global Regulatory Affairs · Teva Pharmaceuticals
Chair
-
Executive Director, Global Policy and Strategy - Asia Pacific, · Eli Lilly and Company
Speaker
-
Structured Data Submission Manager · Novartis Healthcare Private Limited
Speaker
-
Chief Scientific Officer, Numen Health & Founder · Carmel Research Consultancy
Speaker
-
Joint Drugs Controller (India) · Central Drugs Standard Control Organization (CDSCO), Government of India
Speaker
